U.S. mishandling of COVID echoes the 20th century eugenics movement
By Knute Berger,
Crosscut
| 12. 01. 2020
Over the past nine months, I have written about some of the parallels between the 1918-20 influenza pandemic and today’s coronavirus outbreak: opposition to masks, premature elimination of social distancing, increased skepticism about public health, school closures and presidents who made the epidemic a low priority but also caught, and survived, the bug itself.
In the latter case, President Woodrow Wilson, who fell ill in 1919 during treaty talks, was distracted by fighting the first all-out world war. President Donald Trump, on the other hand, became sick after ignoring the advice of his health officials while campaigning for reelection. Trump has long boasted about his health and his smarts. He was hospitalized, given advanced treatments for COVID-19 and, when released, adopted a strongman posture. He and many of his followers believe in their own supremacy — their ability to survive as the fittest of Americans by virtue of their beliefs and their race. White supremacy is, after all, a genetic argument.
Trump has more in common with the prior influenza era: He’s well-known for bragging about his genes. He...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...
